Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

38.66
-1.0000-2.52%
Pre-market: 38.45-0.2100-0.54%08:44 EDT
Volume:4.64M
Turnover:182.75M
Market Cap:4.30B
PE:-27.02
High:41.14
Open:39.80
Low:38.35
Close:39.66
52wk High:41.14
52wk Low:8.47
Shares:111.19M
Float Shares:82.57M
Volume Ratio:0.53
T/O Rate:5.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:17.97
PE(LYR):-25.26

Loading ...

Amylyx Pharmaceuticals Inc - Commercial Launch of Avexitide Anticipated in 2027 IF Approved

THOMSON REUTERS
·
May 05

Amylyx Pharmaceuticals to report first-quarter financial results, host conference call

Reuters
·
Apr 30

Amylyx Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 23

Amylyx to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 08

A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone

Simply Wall St.
·
Apr 07

Amylyx Pharmaceuticals Price Target Maintained With a $34.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 25

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Economic Data Releases

MT Newswires Live
·
Mar 24

Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide

TIPRANKS
·
Mar 24

Amylyx completes enrollment of 78 participants in Phase 3 LUCIDITY trial of avexitide in post-bariatric hypoglycemia

Reuters
·
Mar 24

Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Lucidity Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

THOMSON REUTERS
·
Mar 24

Amylyx Pharmaceuticals Inc - Topline Data Readout for Lucidity Trial Anticipated in Q3 2026

THOMSON REUTERS
·
Mar 24

Amylyx Pharmaceuticals Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 19

Stock Track | Amylyx Pharmaceuticals Soars 5.24% Intraday After H.C. Wainwright Raises Price Target to $34

Stock Track
·
Mar 05

Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 05

Amylyx price target raised to $34 from $28 at H.C. Wainwright

TIPRANKS
·
Mar 04

Amylyx Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $34 From $28

THOMSON REUTERS
·
Mar 04

Stock Track | Amylyx Pharmaceuticals Plummets 5.52% Intraday Following Shelf Offering Announcement

Stock Track
·
Mar 03

Amylyx Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 03

Amylyx files automatic mixed securities shelf

TIPRANKS
·
Mar 03

Amylyx Pharmaceuticals Inc - Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 03